CML is a hematological malignancy that harbors the BCR-ABL fusion gene due to the presence of the Philadelphia chromosome, a specific type of chromosomal translocation between chromosomes 9 and 22 [103]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.